The German Biotechnology Days 2021 will take place on September 20th and 21st at Messe Stuttgart. The two day Program is now available online and the Registration is opened. We look forward to a speech by Federal Minister of Health Jens Spahn and a word of welcome from Baden-Württemberg's Prime Minister Winfried Kretschmann. The topics of the event range from the use of biotechnology for health, nutrition and climate to the bioeconomy. In addition, experts will discuss the financing of the industry and Germany as a location for innovation. The awarding of the BioRegions Innovation Prize will also be part of the programme.
Despite the still uncertain pandemic situation, we are planning a face-to-face event in view of the current positive development. Of course, in compliance with applicable hygiene and distance rules. Details on our hygiene concept, the Corona test center on the forecourt of the exhibition center and other organizational details can be found on the Event Website. If the infection situation does not allow a face-to-face event, we will offer the DBT purely digitally instead.
The DBT is the two-day class reunion of the German biotechnology industry. More than 800 participants from science and research, industry, politics, administration and the media come together for this event every year to exchange ideas. The planning of the conference for 2021 was adapted to the applicable rules of infection protection.
Since 2010, the biotechnology industry association BIO Germany has organized the DBT together with the working group of the German BioRegions at different locations. 2021 in Stuttgart BioRegio STERN is your regional host, partner region is BioLago from the four-country region of Lake Constance.
Further information on this and past DBT can be found here: www.biotechnologietage.de
Enabling medicine that is accessible, personalised, affordable and just for everyone is one of the greatest social challenges of the 21st century. The newly established Center for Medicine Innovation intends to address this challenge. A project team of internationally renowned scientists was selected to develop a viable concept for such a large research center in the former coal region of central Germany.
As part of the structural change project "Innovation Region Central Germany", eleven projects to shape structural change in the region were recently started. This also includes the QualiBioPharma project, which is largely supported in terms of content and financially by the Office for Economic Development and the Department for Employment Policy of the City of Leipzig.